News summary

Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities

Source: Frontiers - Health • Published: 30 Sept 2026, 00:00

Summarized by Masters of Longevity from Frontiers - Health.

Lipid signaling in immunity: a concise editorial preview outlining a thematic collection exploring how lipid pathways shape immune behavior across diseases and tissues.

Editorial: Lipid signaling in immunity: from inflammation and ageing to cancer and therapeutic opportunities
Key Takeaways
  • The articles assembled in this Research Topic extend this view by converging on a central principle: the immunological effects of lipids are determined not by abundance alone, but by molecular identity, metabolic routing, cellular source, tissue localization, and timing.
  • In this sense, context is not simply a modifier of lipid signaling; it is part of the mechanism.
  • Schematic representation of the four complementary settings explored in this Research Topic.
Read the full article at Frontiers - Health ↗

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.